Technical Analysis for ATHA - Athira Pharma, Inc.

Grade Last Price % Change Price Change
F 20.06 -1.04% -0.21
ATHA closed down 1.04 percent on Friday, January 22, 2021, on 3.56 times normal volume. Due to the stock's strong downtrend, it may remain oversold for a while. So, if you're looking for a reason to buy, don't put too much weight on it being oversold.

Trend Table & Recent EOD Signals

ADX Long Term Intermediate Term Short Term
Strong N/A Down Down
Historical ATHA trend table...

Date Alert Name Type % Chg
Volume Surge Other 0.00%
Doji - Bullish? Reversal 0.00%
Lower Bollinger Band Walk Weakness 0.00%
Wide Bands Range Expansion 0.00%
Below Lower BB Weakness 0.00%
Down 3 Days in a Row Weakness 0.00%
Down 4 Days in a Row Weakness 0.00%
Down 5 Days in a Row Weakness 0.00%
Lower Bollinger Band Touch Weakness 0.00%
Oversold Stochastic Weakness 0.00%
Older End-of-Day Signals for ATHA ...

   Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App

Alert Time
60 Minute Opening Range Breakdown about 19 hours ago
Down 1% about 19 hours ago
Rose Above Lower Bollinger Band about 24 hours ago
3x Volume Pace about 24 hours ago
2x Volume Pace about 24 hours ago
View Earlier Intraday Alerts

Get this analysis on your stocks daily!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Athira, headquartered in Seattle, is a drug development company striving to improve human health by advancing bold and innovative therapies with the potential to restore the lives of people impacted by brain disorders. Athira is currently advancing its lead therapeutic candidate, NDX-1017, a novel small molecule therapeutic, in later-stage clinical trials for Alzheimer’s.
Classification

Sector: Healthcare
Industry: Biotechnology
Keywords: Drug Development Nasdaq 100 Index Innovative Therapies Brain Disorders

Is ATHA a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 34.79
52 Week Low 15.79
Average Volume 309,483
200-Day Moving Average 0.00
50-Day Moving Average 26.87
20-Day Moving Average 28.10
10-Day Moving Average 25.36
Average True Range 2.24
ADX 28.52
+DI 11.33
-DI 33.92
Chandelier Exit (Long, 3 ATRs ) 28.07
Chandelier Exit (Short, 3 ATRs ) 26.72
Upper Bollinger Band 35.64
Lower Bollinger Band 20.55
Percent B (%b) -0.03
BandWidth 53.72
MACD Line -1.45
MACD Signal Line -0.30
MACD Histogram -1.1456
Fundamentals Value
Market Cap 651.65 Million
Num Shares 32.5 Million
EPS
Price-to-Sales 0.00
Price-to-Book 3.01
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 22.24
Resistance 3 (R3) 22.46 21.95 21.87
Resistance 2 (R2) 21.95 21.40 21.84 21.75
Resistance 1 (R1) 21.01 21.06 20.76 20.79 21.63
Pivot Point 20.50 20.50 20.38 20.39 20.50
Support 1 (S1) 19.56 19.95 19.31 19.34 18.49
Support 2 (S2) 19.05 19.61 18.94 18.37
Support 3 (S3) 18.11 19.05 18.25
Support 4 (S4) 17.89